rs10459592
From SNPedia
| Orientation | plus |
| Stabilized | plus |
| Make rs10459592(G;G) |
| Make rs10459592(G;T) |
| Make rs10459592(T;T) |
| Reference | GRCh38 38.1/141 |
| Chromosome | 15 |
| Position | 51243944 |
| Gene | CYP19A1 |
| is a | snp |
| is | mentioned by |
| dbSNP | rs10459592 |
| dbSNP (classic) | rs10459592 |
| ClinGen | rs10459592 |
| ebi | rs10459592 |
| HLI | rs10459592 |
| Exac | rs10459592 |
| Gnomad | rs10459592 |
| Varsome | rs10459592 |
| LitVar | rs10459592 |
| Map | rs10459592 |
| PheGenI | rs10459592 |
| Biobank | rs10459592 |
| 1000 genomes | rs10459592 |
| hgdp | rs10459592 |
| ensembl | rs10459592 |
| geneview | rs10459592 |
| scholar | rs10459592 |
| rs10459592 | |
| pharmgkb | rs10459592 |
| gwascentral | rs10459592 |
| openSNP | rs10459592 |
| 23andMe | rs10459592 |
| SNPshot | rs10459592 |
| SNPdbe | rs10459592 |
| MSV3d | rs10459592 |
| GWAS Ctlg | rs10459592 |
| GMAF | 0.4532 |
| Max Magnitude | 0 |
| ? | (G;G) (G;T) (T;T) | 28 |
|---|---|---|
|
| ||
[PMID 21442439] Single nucleotide polymorphisms of CYP19A1 predict clinical outcomes and adverse events associated with letrozole in patients with metastatic breast cancer
[PMID 21319151
] Aromatase (CYP19) promoter gene polymorphism and risk of nonviral hepatitis-related hepatocellular carcinoma.
[PMID 23408108] Regulation of aromatase expression in breast cancer treated with anastrozole neoadjuvant therapy.
[PMID 24803183] Effects of functional genetic polymorphisms in the CYP19A1 gene on prostate cancer risk and survival
Categories:
- Is a snp
- In dbSNP
- SNPs on chromosome 15
- Has genotype
- Has population
- On chip 23andMe v1
- On chip 23andMe v2
- On chip 23andMe v3
- On chip 23andMe v4
- On chip Affy GenomeWide 6
- On chip Ancestry v2
- On chip FTDNA2
- On chip FTDNA
- On chip HumanOmni1Quad
- On chip Illumina Human 1M
- On chip 23andMe v5
- On chip Ancestry v2c
- On chip Ancestry v2d
